Joincare Pharmaceutical Group Industry Co (SHSE:600380) COGS-to-Revenue : 0.37 (As of Mar. 2024)

View and export this data going back to 2001. Start your Free Trial

What is Joincare Pharmaceutical Group Industry Co COGS-to-Revenue?

Joincare Pharmaceutical Group Industry Co's Cost of Goods Sold for the three months ended in Mar. 2024 was ¥1,589 Mil. Its Revenue for the three months ended in Mar. 2024 was ¥4,340 Mil.

Joincare Pharmaceutical Group Industry Co's COGS to Revenue for the three months ended in Mar. 2024 was 0.37.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Joincare Pharmaceutical Group Industry Co's Gross Margin % for the three months ended in Mar. 2024 was 63.39%.

Joincare Pharmaceutical Group Industry Co COGS-to-Revenue Historical Data

The historical data trend for Joincare Pharmaceutical Group Industry Co's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Joincare Pharmaceutical Group Industry Co COGS-to-Revenue Chart

Joincare Pharmaceutical Group Industry Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

COGS-to-Revenue

Get a 7-Day Free Trial

0.36

0.38

Joincare Pharmaceutical Group Industry Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
COGS-to-Revenue	Get a 7-Day Free Trial															0.38	0.37	0.40	0.37	0.37

Joincare Pharmaceutical Group Industry Co COGS-to-Revenue Calculation

Joincare Pharmaceutical Group Industry Co's COGS to Revenue for the fiscal year that ended in Dec. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	6298.465	/	16646.35
	=	0.38

Joincare Pharmaceutical Group Industry Co's COGS to Revenue for the quarter that ended in Mar. 2024 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	1588.615	/	4339.814
	=	0.37

Joincare Pharmaceutical Group Industry Co (SHSE:600380) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Joincare Pharmaceutical Group Industry Co's Gross Margin % for the three months ended in Mar. 2024 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	1588.615 / 4339.814
	=	63.39 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Joincare Pharmaceutical Group Industry Co COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Joincare Pharmaceutical Group Industry Co's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Joincare Pharmaceutical Group Industry Co (SHSE:600380) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Joincare Pharmaceutical Group Industry Co Ltd (SHSE:600380) » Definitions » COGS-to-Revenue

Traded in Other Exchanges

N/A

Address

No. 17 Langshan Road, Joincare Pharmaceutical Group Building, Nanshan New and High-Tech Industrial Development (, Shenzhen, Guangdong, CHN, 518057

Website

http://www.joincare.com

Joincare Pharmaceutical Group Industry Co Ltd is an integrated pharmaceutical company, the business scope covers healthcare products, APIs, final dosage forms, prescription drugs, OTCs, Chinese traditional medicine, chemical drugs, and testing agents. APIs are antibiotic series and their intermediates 7ACA, 4AA and F9. Prescription drugs focus on the realms of the digestive tract, a blood vessel of heart and brain, infection, tumor, nervous cerebrovascular section, urinary system etc. OTCs include gastrointestinal drug Dele-Livzon, Live Bifidobacterium Preparation, oral ulcer drugs Yiketie, cold medicine Antiviral Oral Granule, External use skin medicine.

Executives

Yu Xiong	Directors, senior managers
Zhao Feng Guang	senior management
Qiu Qing Feng	Directors, senior managers
Tang Ling Zhi	senior management
Lin Nan Qi	Directors, senior managers
Cao Ping Wei	Director
Feng Yan Fang	Director
Zhong Shan	senior management
Yang Dong Yun	senior management
Peng Jin Hua	Supervisors
Xie You Guo	Supervisors
Guo Xiao Yun	Supervisors
Su Qing Wen	senior management

Joincare Pharmaceutical Group Industry Co (SHSE:600380) Headlines

No Headlines